Cargando…
Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2
[Image: see text] The outbreak of COVID-19 by the end of 2019 has posed serious health threats to humanity and jeopardized the global economy. However, no effective drugs are available to treat COVID-19 currently and there is a great demand to fight against it. Here, we combined computational screen...
Autores principales: | Liu, Ke, Zou, Rongfeng, Cui, Wenqiang, Li, Meiqing, Wang, Xueying, Dong, Junlin, Li, Hongchun, Li, Hongpei, Wang, Peihui, Shao, Ximing, Su, Wu, Chan, H. C. Stephen, Li, Hongchang, Yuan, Shuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671100/ https://www.ncbi.nlm.nih.gov/pubmed/34778724 http://dx.doi.org/10.1021/acsptsci.0c00163 |
Ejemplares similares
-
Molecular basis of ligand selectivity for melatonin receptors
por: Cui, Wenqiang, et al.
Publicado: (2023) -
MolADI: A Web Server for Automatic Analysis of Protein–Small Molecule Dynamic Interactions
por: Bai, Bing, et al.
Publicado: (2021) -
Rutin, A Natural Inhibitor of IGPD Protein, Partially Inhibits Biofilm Formation in Staphylococcus xylosus ATCC700404 in vitro and in vivo
por: Qu, Qianwei, et al.
Publicado: (2021) -
N(ɛ)-acetyl lysine derivatives with zinc binding groups as novel HDAC inhibitors
por: Wang, Fang, et al.
Publicado: (2019) -
Discovery of a novel AR/HDAC6 dual inhibitor for prostate cancer treatment
por: Zhou, Maojun, et al.
Publicado: (2021)